Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis

Documenti analoghi

• Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1
  di: Allanore, Yannick, et al.
  Pubblicazione: (2004)
• Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers
  di: Allanore, Y, et al.
  Pubblicazione: (2005)
• Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids.
  di: Hurst, N P, et al.
  Pubblicazione: (1984)
• Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis
  di: Vignaux, O, et al.
  Pubblicazione: (2005)
• Role of superoxide anion radicals in ethanol metabolism by blood monocyte-derived human macrophages
  Pubblicazione: (1989)